Altaf Benash, Jawed Shireen, Ghazali Wan Syaheedah Wan, Aziz Ahmad Aizat Abdul, Salam Rana Muhammad Tahir, Rasheed Abid, Mohamed Mahaneem
Benash Altaf, (MBBS, MPhil) Aziz Fatimah Medical and Dental College, Faisalabad, Pakistan.
Shireen Jawed, (MBBS, MPhil) Frontier Medical and Dental College, Abbottabad, Pakistan.
Pak J Med Sci. 2025 May;41(5):1322-1330. doi: 10.12669/pjms.41.5.11532.
To identify the PNPLA3 genetic variants as the potential predictors for metabolic associated fatty liver disease (MAFLD) and its progression among Pakistani population.
A cross sectional study comprising of 158 participants. They were included in this study with non-probability purposive sampling technique from Radiology Department of Aziz Fatimah Teaching Hospital and Aziz Fatimah Medical and Dental College, Pakistan. The duration of study was December 5, 2021 to April 4, 2024. Blood samples (10mL) were drawn for liver enzymes, gene analysis and ultimately PCR products were sent for Sanger sequencing. Data was analyzed using SPSS version 26 with p-Values ≤0.05 considered significant.
From 158 studied participants, 43.7% were male, and 56.3% were female. Of total population 51.3% were MAFLD positive while 48.7% were control subjects. Present results showed that CT and TT genotypes of rs738408 were frequently found in MAFLD group (p=0.039 and 0.060, respectively) and significant predictor for developing MAFLD (OR=2.484, p=0.019 and OR=5.167, p<0.001, respectively). Concerning progression of the disease CT genotype showed that subject with this genotype progress to moderate grade of fatty liver disease (OR=2.832, p=0.013). Whereas Odd ratio for TT genotype was significant for severe grade fatty liver diseases (OR=15.50, p=0.007). GG genotype of rs738409 was frequently found in MAFLD group (p=0.032). Odds ratio for GG genotype of rs738409 was significant for developing MAFLD (OR=4.565, p=0.025) and responsible to progress to moderate grade of fatty liver disease (OR= 5.083, p=0.022).
CT and TT genotypes of 738408 and GG genotype of 738409 are associated with MAFLD and are at more risk for disease progression.
确定PNPLA3基因变异作为巴基斯坦人群中代谢相关脂肪性肝病(MAFLD)及其进展的潜在预测指标。
一项横断面研究,包括158名参与者。采用非概率目的抽样技术,从巴基斯坦阿齐兹·法蒂玛教学医院和阿齐兹·法蒂玛医学与牙科学院放射科纳入本研究。研究持续时间为2021年12月5日至2024年4月4日。采集10mL血液样本用于检测肝酶、基因分析,最终将PCR产物送去进行桑格测序。使用SPSS 26版软件进行数据分析,p值≤0.05被认为具有统计学意义。
在158名研究参与者中,43.7%为男性,56.3%为女性。在总人口中,51.3%为MAFLD阳性,48.7%为对照对象。目前的结果显示,rs738408的CT和TT基因型在MAFLD组中较为常见(p值分别为0.039和0.060),是发生MAFLD的重要预测指标(OR分别为2.484,p=0.019和OR=5.167,p<0.001)。关于疾病进展,CT基因型表明具有该基因型的受试者会进展为中度脂肪性肝病(OR=2.832,p=0.013)。而TT基因型的比值比对于重度脂肪性肝病具有统计学意义(OR=15.50,p=0.007)。rsl738409的GG基因型在MAFLD组中较为常见(p=0.032)。rs738409的GG基因型的比值比对于发生MAFLD具有统计学意义(OR=4.565,p=0.025),并导致进展为中度脂肪性肝病(OR=5.083,p=0.022)。
738408的CT和TT基因型以及738409的GG基因型与MAFLD相关,且疾病进展风险更高。